This is a study to evaluate the efficacy and safety of Belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor (pNET) or von Hippel-Lindau (VHL) Disease-Associated Tumors. The primary objective of t...
- Neuroendocrine Tumors
- Pheochromocytoma
- Adenoma, Islet Cell
- Paraganglioma
- Carotid Body Tumor
- Von Hippel-Lindau Disease
Age: 12 years - 66+
Gender: All